Picture of Sprint Bioscience AB logo

SPRINT Sprint Bioscience AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Sprint Bioscience Q4 Operating Loss Widens To SEK 15.1 Mln

Feb 16 (Reuters) - Sprint Bioscience AB  SPRINT.ST :
    * Q4 NET SALES SEK 0.7 MILLION VERSUS SEK 1.5 MILLION YEAR
AGO
    * Q4 OPERATING LOSS SEK 15.1 MILLION VERSUS LOSS SEK 13.0
MILLION
YEAR AGO
    * PROPOES NO DIVIDEND FOR 2021

Source text for Eikon:  ID:nMFN4Z3NjJ 
Further company coverage:  SPRINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Sprint Bioscience AB

See all news